PCSK9 and its clinical importance with the new therapeutic targets against dyslipidemia

This is a remarkable progress; since the finding of statins, there was no new way of reducing, significantly, cholesterol and LDL fraction. It is also clear that this decrease, by statins, is related to future cardiovascular lesions, being useful in its primary and secondary prophylaxis. The authors...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Carlos Eduardo dos Santos Ferreira [verfasserIn]

Francisco Antônio Helfenstein Fonseca [verfasserIn]

Cristóvão Luis Pitangueira Mangueira [verfasserIn]

Format:

E-Artikel

Sprache:

Englisch ; Portugiesisch

Erschienen:

São Paulo, Vol 10, Iss 4, Pp 526-527

Schlagwörter:

dislipidemias

lipoproteínas

ldl-colesterol

Übergeordnetes Werk:

In: Einstein (São Paulo) - Instituto Israelita de Ensino e Pesquisa Albert Einstein, 2017, (São Paulo, Vol 10, Iss 4, Pp 526-527)

Übergeordnetes Werk:

year:São Paulo, Vol 10, Iss 4, Pp 526-527

Links:

Link aufrufen
Link aufrufen
Link aufrufen
Journal toc
Journal toc

DOI / URN:

10.1590/S1679-45082012000400024

Katalog-ID:

DOAJ002336081

Nicht das Richtige dabei?

Schreiben Sie uns!